1. Home
  2. IMNN vs FEBO Comparison

IMNN vs FEBO Comparison

Compare IMNN & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

N/A

Current Price

$1.00

Market Cap

7.9M

Sector

Health Care

ML Signal

N/A

Logo Fenbo Holdings Limited

FEBO

Fenbo Holdings Limited

N/A

Current Price

$0.65

Market Cap

7.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNN
FEBO
Founded
1982
1993
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9M
7.4M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
IMNN
FEBO
Price
$1.00
$0.65
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $17.00
N/A
AVG Volume (30 Days)
★ 95.7K
7.1K
Earning Date
11-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$0.61
52 Week High
$4.60
$1.46

Technical Indicators

Market Signals
Indicator
IMNN
FEBO
Relative Strength Index (RSI) 36.60 45.21
Support Level N/A $0.65
Resistance Level $1.28 $0.80
Average True Range (ATR) 0.08 0.07
MACD -0.01 -0.01
Stochastic Oscillator 23.08 11.98

Price Performance

Historical Comparison
IMNN
FEBO

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About FEBO Fenbo Holdings Limited

Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.

Share on Social Networks: